Last reviewed · How we verify
Administration of placebo hydrocortisone
Administration of placebo hydrocortisone is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 3 development for Control arm in clinical trials (specific indication depends on parent trial).
Placebo hydrocortisone has no active pharmacological effect, serving as an inert control in clinical trials.
Placebo hydrocortisone has no active pharmacological effect, serving as an inert control in clinical trials. Used for Control arm in clinical trials (specific indication depends on parent trial).
At a glance
| Generic name | Administration of placebo hydrocortisone |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, this intervention contains no active hydrocortisone and produces no direct biological or therapeutic effect. It is used in randomized controlled trials to establish a baseline comparison against active hydrocortisone treatment, allowing researchers to distinguish true drug effects from placebo response and natural disease progression.
Approved indications
- Control arm in clinical trials (specific indication depends on parent trial)
Common side effects
Key clinical trials
- Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin (PHASE2)
- Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency (PHASE4)
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) (PHASE1)
- Plant Protein With Ashwagandha-Rhodiola for Sleep Quality (NA)
- Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery (NA)
- Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease (PHASE2, PHASE3)
- Subjective Experience Following Psilocybin (PHASE2)
- Early Intravenous Hydrocortisone in Sepsis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Administration of placebo hydrocortisone CI brief — competitive landscape report
- Administration of placebo hydrocortisone updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Administration of placebo hydrocortisone
What is Administration of placebo hydrocortisone?
How does Administration of placebo hydrocortisone work?
What is Administration of placebo hydrocortisone used for?
Who makes Administration of placebo hydrocortisone?
What development phase is Administration of placebo hydrocortisone in?
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Indication: Drugs for Control arm in clinical trials (specific indication depends on parent trial)
- Compare: Administration of placebo hydrocortisone vs similar drugs
- Pricing: Administration of placebo hydrocortisone cost, discount & access